Search - tctmd.com

Displaying 41 - 60 of 105

Sort: Relevancy | Date

News Daily News

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Todd Neale

October 22, 2018

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

Manuscript

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

August 14, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Advertisement

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Cerebral Embolic Protection: Point–Counter Point

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content